Seikagaku Corporation (TYO:4548)
Japan · Delayed Price · Currency is JPY 720.00
+7.00 (0.98%)
Aug 26, 2026, 3:30 PM JST
Seikagaku Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 36,747 | 36,645 | 39,374 | 36,213 | 33,456 | 34,851 |
Revenue Growth | -3.51% | -6.93% | 8.73% | 8.24% | -4.00% | 25.99% |
Gross Profit Gross Profit Growth | 15,520 | 15,972 | 19,153 | 16,877 | 18,024 | 20,528 |
Operating Income Operating Income Growth | -1,238 | -660 | 1,334 | 433 | 2,114 | 4,495 |
Net Income Net Income Growth | 1,662 | 1,473 | 1,214 | 2,186 | 2,236 | 3,733 |
Earnings Per Share EPS Growth | 30.44 | 26.98 | 22.25 | 40.07 | 40.48 | 66.31 |
EPS Growth | - | 21.28% | -44.48% | -1.01% | -38.95% | -12.22% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
LAL LAL Growth | 12,708 | 12,152 | 11,860 | 10,271 | 10,732 | 9,155 |
Pharmaceutical Products Pharmaceutical Products Growth | - | - | 27,513 | 25,942 | 22,723 | 25,696 |
Pharmaceutical Products and Related Goods Pharmaceutical Products and Related Goods Growth | - | 24,493 | - | - | - | - |
Total Total Growth | 36,748 | 36,645 | 39,373 | 36,213 | 33,455 | 34,851 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 14,173 | 14,952 | 18,724 | 21,031 | 28,778 | 32,175 |
Total Debt Total Debt Growth | 353 | 356 | 380 | 396 | 389 | 393 |
Net Cash (Debt) Net Cash Growth | 13,820 | 14,596 | 18,344 | 20,635 | 28,389 | 31,782 |
Net Cash Growth | -3.24% | -20.43% | -11.10% | -27.31% | -10.68% | 24.09% |
Net Cash Per Share Net Cash Per Share Growth | 253.11 | 267.35 | 336.14 | 378.25 | 513.93 | 564.52 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -1,347 | 4,429 | 513 | 1,574 | 8,192 |
Capital Expenditures CapEx Growth | - | -5,900 | -4,389 | -4,491 | -1,874 | -1,839 |
Free Cash Flow Free Cash Flow Growth | - | -7,247 | 40 | -3,978 | -300 | 6,353 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 42.23% | 43.59% | 48.64% | 46.61% | 53.87% | 58.90% |
Operating Margin | -3.37% | -1.80% | 3.39% | 1.20% | 6.32% | 12.90% |
Pretax Margin | 4.76% | 4.12% | 4.91% | 4.67% | 9.17% | 15.48% |
Profit Margin | 4.52% | 4.02% | 3.08% | 6.04% | 6.68% | 10.71% |
FCF Margin | - | -19.78% | 0.10% | -10.98% | -0.90% | 18.23% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 30.000 | 30.000 | 30.000 | 26.000 | 26.000 | 20.000 |
Dividend Per Share Growth | 0% | 0% | 15.38% | 0% | 30.00% | 0% |
Dividend Yield | 4.23% | 4.12% | 4.23% | 3.68% | 3.58% | 2.64% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 23.42 | 27.02 | 33.22 | 19.09 | 19.91 | 13.18 |
Forward PE | - | 21.78 | 21.78 | 21.16 | 22.40 | 18.74 |
P/FCF Ratio | - | - | 1008.32 | - | - | 7.75 |
PS Ratio | 1.06 | 1.09 | 1.02 | 1.15 | 1.33 | 1.41 |